NCT02261948View on ClinicalTrials.gov

Levosimendan Efficacy Assessment by Cardiopulmonary Exercise Test (CPET)

PHASE4CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

September 30, 2014

Study Completion Date

December 31, 2014

Conditions
Heart Failure
Interventions
DRUG

Levosimendan

Treatment should be initiated with a loading dose of 6-12 mcg / kg infused over 10 minutes followed by a continuous infusion of 0.1 mcg / kg / min.

DRUG

Placebo

Treatment should be initiated with a loading dose of 6-12 mcg / kg infused over 10 minutes followed by a continuous infusion of 0.1 mcg / kg / min.

Trial Locations (1)

20138

Centro Cardiologico Monzino, Milan

All Listed Sponsors
collaborator

Orion Corporation, Orion Pharma

INDUSTRY

lead

Centro Cardiologico Monzino

OTHER

NCT02261948 - Levosimendan Efficacy Assessment by Cardiopulmonary Exercise Test (CPET) | Biotech Hunter | Biotech Hunter